Quoin Pharmaceuticals Ltd. (QNRX)

SEC filing

Quoin Pharmaceuticals Ltd.

QNRX · CIK 1671502

4 · Sep 1, 2026 · Director, Chief Executive Officer Myers Michael bought 30.73K shares at $3.25/share ($99,991)

Director, Chief Executive Officer Myers Michael bought 30.73K shares at $3.25/share ($99,991)

OWNERSHIP DOCUMENT

xslF345X06/tm2624615-3_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).